KT
Kyverna Therapeutics, Inc. Common Stock
🇺🇸XNAS.KYTXUnited StatesHealthcare
$8.68USDdown -0.22 (-2.47%)OpenEnd of day5:10 PM
Price$8.68-0.22 (-2.47%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US5019761049
- CUSIP
- 501976104
Company
- Employees
- 149
- Headquarters
- EmeryVille, United States
- Website
- https://kyvernatx.com
- CEO
- Mr. Warner Biddle
Market
- Shares outstanding
- 61.8M
- Market cap
- $527.7M
Highlights
- Market cap
- $527.7M
- EPS LTM
- -$2.51
- P/E LTM
- -3.46calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$152.64M+3.82%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$159.43M-12.08%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.